Sumitomo Pharma and Johnson & Johnson announced lists of drugs eligible for refunds.

Sumitomo, J&J Announce 340B Refunds to Covered Entities

March 18, 2025 Bella Czajkowski, National Correspondent Views

Two drugmakers recently notified covered entities of adjustments to their 340B drug ceiling prices and resulting refund eligibility. Sumitomo Pharma [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Sumitomo, J&J Announce 340B Refunds to Covered Entities

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Bella Czajkowski

Sumitomo, J&J Announce 340B Refunds to Covered Entities

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Bella Czajkowski

Site Footer Live